1CT8 image
Deposition Date 1999-08-20
Release Date 1999-11-10
Last Version Date 2024-11-20
Entry Detail
PDB ID:
1CT8
Keywords:
Title:
CATALYTIC ANTIBODY 7C8 COMPLEX
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.27
R-Value Work:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:7C8 FAB FRAGMENT; SHORT CHAIN
Chain IDs:A, C
Chain Length:214
Number of Molecules:2
Biological Source:Mus musculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:7C8 FAB FRAGMENT; LONG CHAIN
Chain IDs:B, D
Chain Length:220
Number of Molecules:2
Biological Source:Mus musculus
Primary Citation
Diverse structural solutions to catalysis in a family of antibodies.
Structure Fold.Des. 7 1385 1393 (1999)
PMID: 10574796 DOI: 10.1016/S0969-2126(00)80028-3

Abstact

BACKGROUND: Small organic molecules coupled to a carrier protein elicit an antibody response on immunisation. The diversity of this response has been found to be very narrow in several cases. Some antibodies also catalyse chemical reactions. Such catalytic antibodies are usually identified among those that bind tightly to an analogue of the transition state (TSA) of the relevant reaction; therefore, catalytic antibodies are also thought to have restricted diversity. To further characterise this diversity, we investigated the structure and biochemistry of the catalytic antibody 7C8, one of the most efficient of those which enhance the hydrolysis of chloramphenicol esters, and compared it to the other catalytic antibodies elicited in the same immunisation. RESULTS: The structure of a complex of the 7C8 antibody Fab fragment with the hapten TSA used to elicit it was determined at 2.2 A resolution. Structural comparison with another catalytic antibody (6D9) raised against the same hapten revealed that the two antibodies use different binding modes. Furthermore, whereas 6D9 catalyses hydrolysis solely by transition-state stabilisation, data on 7C8 show that the two antibodies use mechanisms where the catalytic residue, substrate specificity and rate-limiting step differ. CONCLUSIONS: Our results demonstrate that substantial diversity may be present among antibodies catalysing the same reaction. Therefore, some of these antibodies represent different starting points for mutagenesis aimed at boosting their activity. This increases the chance of obtaining more proficient catalysts and provides opportunities for tailoring catalysts with different specificities.

Legend

Protein

Chemical

Disease

Primary Citation of related structures